228 related articles for article (PubMed ID: 19652625)
1. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Sep; 4(9):1083-93. PubMed ID: 19652625
[TBL] [Abstract][Full Text] [Related]
2. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
[TBL] [Abstract][Full Text] [Related]
3. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2010 Feb; 5(2):158-68. PubMed ID: 20040896
[TBL] [Abstract][Full Text] [Related]
4. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era.
Ahn MJ; Lee J; Park YH; Ahn JS; Ziogas A; Zell JA; Park K; Ou SH
J Thorac Oncol; 2010 Aug; 5(8):1185-96. PubMed ID: 20592628
[TBL] [Abstract][Full Text] [Related]
5. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
[TBL] [Abstract][Full Text] [Related]
7. Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer.
Gibson AJW; D'Silva A; Elegbede AA; Tudor RA; Dean ML; Bebb DG; Hao D
Asia Pac J Clin Oncol; 2019 Dec; 15(6):343-352. PubMed ID: 31486229
[TBL] [Abstract][Full Text] [Related]
8. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
[TBL] [Abstract][Full Text] [Related]
10. Hispanics/Latinos in the Bronx Have Improved Survival in Non-Small Cell Lung Cancer Compared with Non-Hispanic Whites.
Klugman M; Xue X; Ginsberg M; Cheng H; Rohan T; Hosgood HD
J Racial Ethn Health Disparities; 2020 Apr; 7(2):316-326. PubMed ID: 31713221
[TBL] [Abstract][Full Text] [Related]
11. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
[No Abstract] [Full Text] [Related]
13. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
[TBL] [Abstract][Full Text] [Related]
14. Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Cortellini A; De Giglio A; Cannita K; Cortinovis DL; Cornelissen R; Baldessari C; Giusti R; D'Argento E; Grossi F; Santoni M; Catino A; Berardi R; Sforza V; Rossi G; Antonuzzo L; Di Noia V; Signorelli D; Gelibter A; Occhipinti MA; Follador A; Rastelli F; Chiari R; Gravara LD; Inno A; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Montrone M; Citarella F; Pensieri MV; Russano M; Cantini L; Nigro O; Leonetti A; Bordi P; Minuti G; Landi L; De Toma A; Donisi C; Ricciardi S; Migliorino MR; Napoli VM; Leone G; Metro G; Banna GL; Friedlaender A; Addeo A; Ficorella C; Porzio G
Thorac Cancer; 2021 Mar; 12(6):880-889. PubMed ID: 33527756
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
17. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.
Janjigian YY; McDonnell K; Kris MG; Shen R; Sima CS; Bach PB; Rizvi NA; Riely GJ
Cancer; 2010 Feb; 116(3):670-5. PubMed ID: 20029977
[TBL] [Abstract][Full Text] [Related]
18. Difference in survival and prognostic factors between smokers and never-smokers with advanced non-small-cell lung cancer.
Tanaka S; Yanagihara K; Tamaru S; Teramukai S; Kitano T; Fukushima M
Int J Clin Oncol; 2013 Feb; 18(1):17-25. PubMed ID: 22072116
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
[TBL] [Abstract][Full Text] [Related]
20. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
